Twenty-two studies were identified (n=2,596 participants, range 15 to 322): 18 retrospective studies with historical controls (n=2,245, range 15 to 322) and four prospective studies (n=351, range 50 to 176). Sixteen studies provided quantitative data that could be used in the meta-analysis. All studies had a clear objective and were controlled. None of the studies were randomised or blinded. Most studies had adequate follow-up and used an intention-to-treat analysis. There were baseline differences between patient groups in approximately one half of the studies.
Hysterectomy for the staging of endometrial cancer (six studies): There were significantly fewer complications with DVSS versus open surgery (OR 0.22, 95% CI 0.13 to 0.39, I2=37%; four studies) and no significant difference for DVS versus CLS (three studies, I2=0%). There was significantly lower blood loss for DVSS versus open surgery (MD -152.1mL, 95% CI -184.2 to -120.0, I2=56%; four studies) and DVSS versus CLS (MD -76.0mL, 95% CI -142.4 to -9.5, I2=88%; four studies). There was a significantly lower need for blood transfusion for DVSS versus open surgery (OR 0.25, 95% CI 0.07 to 0.81, I2=0%; three studies) and for DVSS versus CLS (OR 0.24, 95% CI 0.09 to 0.64, I2=0%; three studies). There was a shorter hospital stay for DVSS versus open surgery (MD -2.68 days, 95% CI -3.53 to -1.84, I2=93%; four studies) and DVSS versus CLS (MD -0.17 days, 95% CI -0.28 to -0.06, I2=45%; four studies). Operation duration was significantly longer for DVSS versus open surgery (MD 89.3 minutes, 95% CI 51.7 to 126.8, I2=95%; four studies) with no significant difference for DVSS versus CLS (I2=85%, four studies). There was a greater risk of conversion to another type of surgery for DVSS versus open surgery (OR 11.5, 95% CI 1.4 to 95.0, I2=0%; two studies) but a reduced risk of conversion for DVSS versus CLS (OR 0.43, 95% CI 0.21 to 0.85, I2=0%; two studies). There was an increased number of resected lymph nodes for DVSS versus open surgery (MD 5.91, 95% CI 0.13 to 11.68, I2=90%; four studies) but no significant difference for DVSS versus CLS (I2=80%; four studies) and no significant differences for the number of pelvic lymph nodes or aortic lymph nodes resected for either comparison.
Radical hysterectomy for cervical cancer (seven studies): There was significantly lower blood loss for DVSS versus open surgery (MD -334.2mL, 95% CI -459.4 to -208.9, I2=90%; five studies) and DVSS versus CLS (MD -63.5mL, 95% CI -100.5 to -26.5, I2=0%; three studies). Similarly, there was a significantly lower need for blood transfusion for DVSS versus open surgery (OR 0.18, 95% CI 0.07 to 0.44, I2=0%; five studies) but not for DVSS versus CLS (I2=0%, two studies). There was a shorter hospital stay for DVSS versus open surgery (MD -2.05 days, 95% CI -2.80 to -1.29, I2=80%; five studies) but no significant difference for DVSS versus CLS (I2=51%; three studies) with no significant difference in operation duration for DVSS versus open surgery (I2=94%, five studies) or versus CLS (I2=68%, four studies). There were no significant differences for complications for DVSS versus open surgery (I2=0%, five studies) or CLS (I2=11%, four studies), need for conversion to another type of surgery (DVSS versus open surgery I2=0%, two studies and DVSS versus CLS, I2=0%, three studies) and numbers of lymph nodes resected (DVSS versus open surgery I2=86%, five studies and DVSS versus CLS, I2=94%, three studies).
Fallopian tube reanastomosis (two studies both comparing DVSS versus open surgery): Duration of operation was significantly longer for DVSS versus open surgery (MD 46.9 minutes, 95% CI 34.7 to 59.0, I2=0%). There was a significantly earlier return to work for DVSS versus open surgery patients (MD -16.0 days, 95% CI -19.6 to -12.4, I2=0%). There were no significant differences for hospital stay, complications, blood loss, pregnancy rate, miscarriage and ectopic and uterine pregnancies. Both studies reported increased costs for robotic surgery.
Myomectomy (three studies): There was significantly lower blood loss for DVSS versus CLS (MD -72.4mL, 95% CI -133.2 to -11.5, I2=44%; two studies) and no significant difference for duration of surgery (I2=76%, two studies). One study compared DVSS with open surgery with significantly lower duration of operation, lower blood loss, shorter hospital stay and increased costs for DVSS versus open surgery.
Individual studies: A large study of hysterectomy for benign disease found significantly longer duration of operation, shorter duration of hospital stay and lower blood loss for DVSS versus CLS. A study of sacrocolopexy found significantly longer duration of operation, shorter hospital stay and lower blood loss, but a higher risk of postoperative fever for DVSS versus open surgery. Adnexectomy: The only significant outcome was a longer duration of surgery for DVSS versus CLS.
Other individual results and results for a subgroup of obese patients were reported.